Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Daniel Sur"'
Autor:
Mohammad Taghizadeh, Tohid Jafari-Koshki, Vahid Jafarlou, Mortaza Raeisi, Leila Alizadeh, Yousef Roosta, Somaieh Matin, Rahele Jabari, Daniel Sur, Abbas Karimi
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Introduction This article examines the potential of using liquid biopsy with piRNAs to study cancer survival outcomes. While previous studies have explored the relationship between piRNA expression and cancer patient outcomes, a comprehensiv
Externí odkaz:
https://doaj.org/article/48b2c5e7ed6449f8b327cfaea7a04174
Autor:
Daniel Sur, Constantin Ionut Coroama, Alessandro Audisio, Roberta Fazio, Maria Coroama, Cristian Virgil Lungulescu
Publikováno v:
Journal of Personalized Medicine, Vol 14, Iss 5, p 520 (2024)
Background: Arterial hypertension is regarded as a possible biomarker of treatment efficacy in colorectal cancer. Also, extended anti-angiogenic use in the metastatic treatment of the colorectal neoplasm may result in elevated blood pressure. We carr
Externí odkaz:
https://doaj.org/article/4b9e73d198d24cc197bcdcf7a2cbefe9
Autor:
Alexandru Dorin Adrian Silași, Anna Carolin Sievert, Paul Danciu, Andrei Vlad Lefter, Vlad Adrian Afrasanie, Daniel Sur
Publikováno v:
Diagnostics, Vol 14, Iss 6, p 654 (2024)
Background: This retrospective study evaluates patients with stage IV melanoma treated with nivolumab and ipilimumab combination therapy from two regional oncology centers in Romania from the year 2019 to the end of 2022. Methods: The data were analy
Externí odkaz:
https://doaj.org/article/7c52705f37a7445ea1b09f29ec819a3b
Autor:
Simona Ruxandra Volovat, Dragos Viorel Scripcariu, Ingrid Andrada Vasilache, Cati Raluca Stolniceanu, Constantin Volovat, Iolanda Georgiana Augustin, Cristian Constantin Volovat, Madalina-Raluca Ostafe, Slevoacă-Grigore Andreea-Voichița, Toni Bejusca-Vieriu, Cristian Virgil Lungulescu, Daniel Sur, Diana Boboc
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 2, p 1180 (2024)
Oncolytic viruses (OVs) are emerging as potential treatment options for cancer. Natural and genetically engineered viruses exhibit various antitumor mechanisms. OVs act by direct cytolysis, the potentiation of the immune system through antigen releas
Externí odkaz:
https://doaj.org/article/d13a360fca054e9e89e02c7e3c323d7b
Publikováno v:
Life, Vol 13, Iss 12, p 2300 (2023)
(1) Background: Following the results of RAINBOW and REGARD trials, ramucirumab was approved as the standard second-line treatment for patients with advanced or metastatic gastric or gastroesophageal junction (GEJ) cancer, alone or in combination wit
Externí odkaz:
https://doaj.org/article/bd59da45669248a28c0be529a99e3576
Autor:
Vlad-Adrian Afrăsânie, Mihai-Vasile Marinca, Bogdan Gafton, Teodora Alexa-Stratulat, Alexandra Rusu, Eliza-Maria Froicu, Daniel Sur, Cristian Virgil Lungulescu, Larisa Popovici, Andrei-Vlad Lefter, Irina Afrăsânie, Anca-Viorica Ivanov, Lucian Miron, Cristina Rusu
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 16, p 12679 (2023)
Mutations in RAS, BRAF, PIK3CA, and TP53 are well-established genetic abnormalities in metastatic colorectal cancer (mCRC). However, limited information is available for patients from Eastern Europe, including Romania. In this retrospective analysis,
Externí odkaz:
https://doaj.org/article/c540fed0715c4dcdb4988c00195ea9ae
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundCirculating microRNAs (miRNA) have emerged as promising diagnostic biomarkers for several diseases, including cancer. However, the diagnostic accuracy of miRNA panels in colorectal cancer (CRC) remains inconsistent and there is still lack o
Externí odkaz:
https://doaj.org/article/694e9f23786147f8a13aed5f82680fb7
Autor:
Khalid El Bairi, Harry R. Haynes, Elizabeth Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Fujimoto, Luz F. Sua, Shi-Wei Liu, Huang-Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I-Chun Chen, Veronica Bautista, Jose Fernando Do Prado Moura, Bernardo L. Rapoport, Carlos Castaneda, Eunice Spengler, Gabriela Acosta-Haab, Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard-Gallo, An Coosemans, Edith A. Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M. S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, William Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernan Garcia-Rivello, Hugo Horlings, Said Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-17 (2021)
Abstract The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of pr
Externí odkaz:
https://doaj.org/article/98d18f7227c34bcb8909cccb39302c30
Autor:
Daniel Sur, Cristina Lungulescu, Ștefan Spînu, Alecsandra Gorzo, Elena-Adriana Dumitrescu, Dan Ionut Gheonea, Cristian-Virgil Lungulescu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: In the phase III RECOURSE trial, the orally administered combination trifluridine/tipiracil (FTD/TPI) demonstrated a survival benefit and an acceptable safety profile, earning approval as a third-line therapy in metastatic colorectal canc
Externí odkaz:
https://doaj.org/article/1c58b5c6047648c7be133e32cbf8bed0
Autor:
Vlad-Adrian Afrăsânie, Teodora Alexa-Stratulat, Bogdan Gafton, Eliza-Maria Froicu, Daniel Sur, Cristian Virgil Lungulescu, Natalia Gherasim-Morogai, Irina Afrăsânie, Lucian Miron, Mihai-Vasile Marinca
Publikováno v:
Cancers, Vol 15, Iss 4, p 1265 (2023)
We performed a retrospective study on 51 metastatic melanoma patients treated with Nivolumab in first line, at the Regional Institute of Oncology (RIO) Iasi, Romania between April 2017 and December 2019. We studied the efficacy and safety of anti-PD-
Externí odkaz:
https://doaj.org/article/4cb63571bb1b413187aea7f30e9e8618